Institution
Agence Nationale de la Recherche
Government•Paris, France•
About: Agence Nationale de la Recherche is a government organization based out in Paris, France. It is known for research contribution in the topics: Behavioral economics & Public health. The organization has 22 authors who have published 25 publications receiving 403 citations.
Papers
More filters
University of Göttingen1, Örebro University2, King's College London3, Guy's and St Thomas' NHS Foundation Trust4, Charité5, Claude Bernard University Lyon 16, University of Jena7, Radboud University Nijmegen8, Agence Nationale de la Recherche9, University Hospital Heidelberg10, University of Duisburg-Essen11, University of Amsterdam12, Carlos III Health Institute13, University of Bern14, University of Barcelona15, National and Kapodistrian University of Athens16, Hebron University17, University of Modena and Reggio Emilia18, University of Medicine and Pharmacy of Craiova19, University of Bonn20
TL;DR: The authors reviewed the intricacies of COVID-19 pathophysiology, its various phenotypes, and the anti-SARS-CoV-2 host response at the humoral and cellular levels.
325 citations
National Institutes of Health1, French Institute of Health and Medical Research2, Agence Nationale de la Recherche3, Shire plc4, Genetic Alliance5, European Organisation for Rare Diseases6, Chiesi Farmaceutici S.p.A.7, Children's Hospital of Eastern Ontario8, King Edward Memorial Hospital9, Istituto Superiore di Sanità10, Newcastle University11, Japan Agency for Medical Research and Development12, Genzyme13, Directorate-General for Research and Innovation14, Government of Western Australia15
TL;DR: This poster presents a poster presented at the 2016 U.S.L.A. Conference of the International Rare Diseases Research Consortium (IRDiRC) on apoptosis-guided cell reprograming of the immune system to treat central nervous system disorders.
Abstract: Christopher P. Austin1,∗, Christine M. Cutillo1, Lilian P.L. Lau2, Anneliene H. Jonker2, Ana Rath2,3, Daria Julkowska4, David Thomson5, Sharon F. Terry6, Béatrice de Montleau7, Diego Ardigò8, Virginie Hivert7, Kym M. Boycott9, Gareth Baynam10,11, Petra Kaufmann1, Domenica Taruscio12, Hanns Lochmüller13, Makoto Suematsu14, Carlo Incerti15, Ruxandra Draghia-Akli16,17, Irene Norstedt16, Lu Wang18 and Hugh J.S. Dawkins19 on behalf of the International Rare Diseases Research Consortium (IRDiRC)
131 citations
TL;DR: In this paper, the authors study the role of plant richness on people's perception of the services provided by the park and propose several recommendations for improving biodiversity conservation in green parks without undermining the park users' well-being.
70 citations
TL;DR: Several examples of funded pre-clinical and clinical gene therapy projects show that integration of multinational and multidisciplinary expertize generates new knowledge and can result in multicentre gene therapy trials.
Abstract: Over the last two decades, important contributions were made at national, European and international levels to foster collaboration into rare diseases research. The European Union (EU) has put much effort into funding rare diseases research, encouraging national funding organizations to collaborate together in the E-Rare program, setting up European Reference Networks for rare diseases and complex conditions, and initiating the International Rare Diseases Research Consortium (IRDiRC) together with the National Institutes of Health in the USA. Co-ordination of the activities of funding agencies, academic researchers, companies, regulatory bodies, and patient advocacy organizations and partnerships with, for example, the European Research Infrastructures maximizes the collective impact of global investments in rare diseases research. This contributes to accelerating progress, for example, in faster diagnosis through enhanced discovery of causative genes, better understanding of natural history of rare diseases through creation of common registries and databases and boosting of innovative therapeutic approaches. Several examples of funded pre-clinical and clinical gene therapy projects show that integration of multinational and multidisciplinary expertize generates new knowledge and can result in multicentre gene therapy trials. International collaboration in rare diseases research is key to improve the life of people living with a rare disease.
55 citations
TL;DR: In this paper, a review of recent research developed in behavioral economics on the determinants of unethical behavior is presented, focusing on the importance of moral norms in individual decision-making, the conflicting role of opportunities provided by asymmetries of information and social preferences, and the crucial effect of rules, occupational norms and incentive schemes in the diffusion of dishonesty.
Abstract: This review surveys recent research developed in behavioral economics on the determinants of unethical behavior. Most recent progress has been made in three directions: the understanding of the importance of moral norms in individual decision-making, the conflicting role of opportunities provided by asymmetries of information and social preferences, and the crucial effect of rules, occupational norms and incentive schemes in the diffusion of dishonesty. The connection between economics and psychology is the most vivid on the first dimension.
45 citations
Authors
Showing all 22 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Marie Claire Villeval | 38 | 335 | 7013 |
| Nadège Varsier | 14 | 44 | 940 |
| Katia Meziani | 8 | 18 | 146 |
| Jean-Charles Moretti | 5 | 31 | 95 |
| Anne Hélène Prieur-Richard | 5 | 6 | 826 |
| Cathy Cohen | 5 | 15 | 67 |
| Audrey Mazur-Palandre | 4 | 30 | 60 |
| Patrice Baubeau | 4 | 19 | 74 |
| Emilie Ailhaud | 3 | 7 | 58 |
| Daria Julkowska | 3 | 3 | 123 |
| Aladji Kamagaté | 2 | 9 | 19 |
| Teddy Arrif | 1 | 1 | 57 |
| Julia Csergo | 1 | 1 | 1 |
| Édouard Saint-Michel | 1 | 1 | 8 |
| Jean-Marc Cavaillon | 1 | 3 | 64 |